 |
| | Business Summary: Remedent, Inc., through it subsidiaries, engages in the research, development, manufacture, and distribution of oral care and cosmetic dentistry products in Europe, Asia, and the United States. It offers professional dental and retail over-the-counter tooth whitening products. | | | Address
Xavier de Cocklaan 42
Deurle 9831
Phone: 011-329-321-7080
Website: http://www.remedent.be
| | Auditor |
|---|
PKF Bedrijfsrevisoren
Antwerp
Belgium
| | Transfer Agent |
|---|
Interwest Transfer Co. Inc.
| Employees: 22
ShareHolders: 196 | Founded: 1986
Domicile: Nevada | | | |
| | Remedent, Inc., through it subsidiaries, engages in the research, development, manufacture, and distribution of oral care and cosmetic dentistry products in Europe, Asia, and the United States. It offers professional dental and retail over-the-counter tooth whitening products. The company's dental product includes GlamSmile, an ultra thin claddings that are attached to the front of the patient's teeth and dentists need not remove healthy tooth structure leaving the patient's healthy tooth structure intact; and FirstFit, a system for the creation and placement of dental bridges and crowns. It also provides RemeWhite in office whitening system; MetaTray, a self-contained whitening system; RemeCure plasma curing light, which is used for curing dental composite materials and in-office whitening; and Remewhite home maintenance kit, a 16 pre-filled trays with whitening agent for home use. The company offers its products through its sales force and third party distributors. Remedent, Inc. was founded in 1986 and is headquartered in Deurle, Belgium. | | History: INCORPORATED in Nevada July 31, 1986, as Jofran Confectioners International, Inc. to merge a Utah company of the same name (incorporated Nov. 9, 1983). Name changed to Cliff Typographers, Inc. July 31, 1986; to Cliff Graphics International, Inc. Jan. 9, 1987; to Global Golf Holdings, Inc. Mar. 8, 1995; to Dino Minichiello Fashions, Inc. Nov. 20, 1997; to Resort World Enterprises, Inc. Aug. 18, 1998; to Remedent USA, Inc. Oct. 5, 1998; and to Remedent, Inc. June 3, 2005.
June 3, 2005, issued 7,715,703 post reverse split Common shares in exchange for the 78% of Remedent N.V. not owned by the company. As a result of this acquisition, Remedent N.V. became a wholly owned subsidiary of the company. | | | | Subsidiaries: |
|---|
Glamtech-USA, Inc.
Remedent Asia Pte Ltd
Remedent N.V.
Remedent OTC BV
Remedent Professional Holdings, Inc.
Remedent Professional, Inc.
Sylphar Holding, BV
Sylphar N.V.
Sylphar USA, Inc.
| | | | | | Capital Expenditures, thousand. US Dollars |
|---|
| Year | Amount | | 2008 | 199 |
| | | | | | Research and Development Expenditures, thousand. US Dollars |
|---|
| Year | Amount | | 2008 | 333 |
| | | | | |
|
Management
|
|---|
| Officers | Position |
|---|
| Guy De Vreese | Chairman & Chief Executive Officer | | Stephen F. Ross | Secretary & Chief Financial Officer | | Philippe Van Acker | Chief Accounting Officer & Controller | | Ron Both | Investor Relations Contact |
| | Directors |
|---|
| Guy De Vreese | | Fred Kolsteeg | | Stephen F. Ross | | Philippe Van Acker | | | |
| | | | Capitalization as of 03/31/2009: | | | | | Authorized Shares | Outstanding Shares |
|---|
| Preferred $0.001 par | 10,000,000 | None | | Common $0.001 par | 50,000,000 | 19,272,969so2 |
| | | | LONG TERM DEBT: $100,542. | | | | Common $0.001 par | | | |
Stockholders:
06/04/2009,
196.
| | PRINCIPAL STOCKHOLDERS: June 4, 2009, Austin W. Marxe and David M. Greenhouse owned or controlled 33.5% of the Common, Guy De Vreese 23.8%, Den-Mat Holdings, LLC 14.5% and Jon D. Gruber, J. Patterson McBaine and Eric Swergold 10.7%. | | | |
Transfer Agent: Interwest Transfer Co. Inc.
Salt Lake City
, UT | | | | OTC Bulletin Board( Primary): REMI | | | | Exchange | Year | High | Low |
|---|
| OTC Bulletin Board | 2009 | 1.0100 | 0.2000 | | OTC Bulletin Board | 2008 | 1.9000 | 0.3000 | | OTC Bulletin Board | 2007 | 3.1500 | 1.3700 | | OTC Bulletin Board | 2006 | 3.2500 | 0.9500 | | OTC Bulletin Board | 2005 | 4.0000 | 0.8000 | | OTC Bulletin Board | 2004 | 4.0000 | 0.6000 | | OTC Bulletin Board | 2003 | 2.4000 | 0.6000 |
|
| | | | RECENT DIVIDENDS: Common $0.001 par: No cash.
Common reverse split 1-for-20, June 6, 2005. | | | | | |
so2Excl. 723,000 in treas. | |
| | Annual Report |
|---|
| | | Income Statement | |
| 2009 | 2008 |
|---|
| REVENUES |
|
| | Net Sales | 14,639,541 | 7,482,261 | | EXPENSES |
|
| | Cost of Sales | (6,614,723) | (3,975,777) | | Sales and Marketing | (2,793,970) | (1,886,389) | | General and Administrative | (5,312,192) | (4,057,007) | | Research and Development | (248,652) | (332,958) | | Depreciation and Amortization | (615,674) | (301,260) | | Gain on Disposition of Otc | 2,830,953 | - | | Interest Expense and Other Deductions | (417,147) | (138,168) | | Interest Income/Other Income | 348,997 | - | | Warrants Issued Pursuant to Distribution Agreement | (4,323,207) | - | | Imds Provision | (300,000) | - | | Other Income | - | 121,032 | | Earnings before Taxes | (2,806,074) | (3,088,266) | | TAXES AND OTHER EXPENSES |
|
| | Provision for Income Tax | (32,633) | (27,247) | | Minority Interest (After Tax) | (114,208) | - | | Net Income (Loss) | (2,952,915) | (3,115,513) | | SUPPLEMENTARY INFO |
|
| | Gross Profit/loss | 8,024,818 | 3,506,484 | | Operating Income (Loss) | (945,670) | (3,071,130) | | LOSS PER SHARE: Basic and fully diluted | (0.15) | (0.17) |
| | | | Balance Sheet | |
| 2009 | 2008 |
|---|
| ASSETS |
|
| | Cash and Cash Equivalents | 1,807,271 | 1,728,281 | | Accounts Receivables | 3,208,120 | 1,902,920 | | Inventories (Net) | 1,937,946 | 1,360,709 | | Prepaid Expenses | 1,310,900 | 970,173 | | Total Current Assets | 8,264,237 | 5,962,083 | | NON CURRENT ASSETS |
|
| | Property and Equipment, net | 1,024,999 | 692,609 | | Long-term Investments and Advances | 750,000 | 675,000 | | Patents-net | 163,106 | 115,827 | | Total Assets | 10,202,342 | 7,445,519 | | LIABILITIES |
|
| | Accounts Payable | 1,398,420 | 2,002,439 | | Accrued Liabilities | 1,590,360 | 781,737 | | Line-of-credit | 660,200 | 779,718 | | Current Portion Long-term-debt | 78,798 | 58,583 | | Income Taxes Payable | 39,339 | 15,121 | | Total Current Liabilities | 3,767,117 | 3,637,598 | | NON CURRENT LIABILITIES |
|
| | Long-term Debt-less Current Portion | 100,542 | 94,754 | | Minority Interest | 896,705 | - | | SHAREHOLDERS' EQUITY |
|
| | Common Stock-par Value | 19,996 | 18,638 | | Additional Paid in Capital | 24,106,056 | 17,929,992 | | Treasury Stock-common | (831,450) | - | | Accumulated Deficit | (17,216,028) | (14,263,113) | | Accumulated Other Comprehensive Income (Loss) Foreign Currency Translation Adjustment | (640,595) | 27,650 | | Total Shareholders Equity | 5,437,978 | 3,713,167 | | Total Liabilities & Shareholders Equity | 10,202,342 | 7,445,519 |
| | | |
| | Interim Report
|
|---|
| | | Data Not Available | | | | | | | | | |
| | Pro Forma Report
|
|---|
| | | Data Not Available | | | | | | | | | |
| | Quarterly Report Information
|
|---|
| | | Quarterly Revenue, US$ |
|---|
| Year | Quarter | Revenue | | 2010 |
1 | 2,160,000 | | 2010 |
2 | 1,780,000 | | 2009 |
1 | 3,640,000 | | 2009 |
2 | 2,770,000 | | 2009 |
3 | 4,840,000 | | 2009 |
4 | 3,390,000 | | 2009 |
Full Year
| 14,640,000 | | 2008 |
1 | 1,240,000 | | 2008 |
2 | 1,080,000 | | 2008 |
3 | 2,130,000 | | 2008 |
4 | 3,030,000 | | 2008 |
Full Year
| 7,480,000 | | 2007 |
1 | 1,300,000 | | 2007 |
2 | 2,420,000 | | 2007 |
3 | 1,160,000 | | 2007 |
4 | 1,810,000 | | 2007 |
Full Year
| 6,680,000 | | 2006 |
1 | 1,380,000 | | 2006 |
2 | 1,430,000 | | 2006 |
3 | 1,870,000 | | 2006 |
4 | 2,710,000 | | 2006 |
Full Year
| 7,390,000 | | 2005 |
1 | 1,760,000 | | 2005 |
2 | 1,340,000 | | 2005 |
3 | 2,010,000 | | 2005 |
4 | 1,970,000 | | 2005 |
Full Year
| 7,070,000 |
| | | | | | Quarterly Net Income, US$ |
|---|
| Year | Quarter | Revenue | | 2009 |
1 | (490,000) | | 2009 |
2 | (840,000) | | 2009 |
Full Year
| (2,950,000) | | 2008 |
1 | 330,000 | | 2008 |
2 | (4,690,000) | | 2008 |
3 | 2,480,000 | | 2008 |
Full Year
| (3,120,000) | | 2007 |
3 | (1,100,000) | | 2007 |
4 | (620,000) | | 2007 |
Full Year
| (1,500,000) | | 2006 |
Full Year
| (3,887,000) | | 2005 |
Full Year
| (103,000) |
| | | | | | Quarterly EPS, US$ |
|---|
| Year | Quarter | Revenue | | 2010 |
1 | (.02) | | 2010 |
2 | (.04) | | 2009 |
1 | .01 | | 2009 |
2 | (.25) | | 2009 |
3 | .13 | | 2009 |
4 | (.05) | | 2009 |
Full Year
| (.15) | | 2008 |
1 | (.03) | | 2008 |
2 | (.05) | | 2008 |
3 | (.06) | | 2008 |
4 | (.03) | | 2008 |
Full Year
| (.17) | | 2007 |
1 | (.06) | | 2007 |
2 | (.01) | | 2007 |
3 | (.05) | | 2007 |
4 | .01 | | 2007 |
Full Year
| (.11) | | 2006 |
1 | (.32) | | 2006 |
2 | (.02) | | 2006 |
3 | (.13) | | 2006 |
4 | (.08) | | 2006 |
Full Year
| (.35) | | 2005 |
1 | .03 | | 2005 |
2 | .02 | | 2005 |
3 | (.04) | | 2005 |
4 | (.05) | | 2005 |
Full Year
| (.05) |
| | | |
| |
|
